Cognition Therapeutics (CGTX) Capital Expenditures (2022 - 2024)
Cognition Therapeutics (CGTX) posted quarterly Capital Expenditures of $1000.0 for Q4 2024, down 96.67% year-over-year from $30000.0 in Q1 2024, and down 96.67% quarter-over-quarter from $30000.0 in Q4 2023.
Cognition Therapeutics (CGTX) Capital Expenditures (2022 - 2024) Analysis & Trends
Cognition Therapeutics (CGTX) has reported Capital Expenditures for 3 consecutive years, with $1000.0 the latest figure, recorded in Q4 2024.
- In Q4 2024, Capital Expenditures fell 96.67% year-over-year to $1000.0; the TTM figure through Dec 2024 stood at $89000.0 (down 39.46% YoY), while the FY2024 annual figure was $4000.0, down 97.28% from the prior year.
- Capital Expenditures slipped to $1000.0 in Q4 2024 per CGTX's latest filing, from $30000.0 in the prior quarter.
- Across five years, Capital Expenditures topped out at $134000.0 in Q1 2022 and bottomed at $1000.0 in Q4 2024.
- Historically, Capital Expenditures has averaged $35444.4 across 3 years, with a median of $23000.0 in 2022.
- Annual changes were most pronounced in 2023 — Capital Expenditures jumped 350.0% — and 2024, when it tumbled 96.67%.
- Cognition Therapeutics' Capital Expenditures stood at $10000.0 in 2022, then surged by 200.0% to $30000.0 in 2023, then slumped by 96.67% to $1000.0 in 2024.
- Business Quant data shows CGTX's Capital Expenditures at $1000.0 in Q4 2024, $30000.0 in Q4 2023, and $58000.0 in Q3 2023.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Capex (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 112.20 Mn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 240.20 Mn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | - |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 37.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 25.02 Mn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 34.68 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | -73.57 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 6.26 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 251.02 Mn |
| 10 | Cognition Therapeutics | 90.18 Mn | 90.18 Mn | - | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2024 | 1,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Dec 31, 2023 | 30,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Sep 30, 2023 | 58,000.00 |
| Jun 30, 2023 | 18,000.00 |
| Jun 30, 2023 | 18,000.00 |
| Mar 31, 2023 | 41,000.00 |
| Mar 31, 2023 | 41,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Dec 31, 2022 | 10,000.00 |
| Sep 30, 2022 | 23,000.00 |
| Sep 30, 2022 | 23,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Jun 30, 2022 | 4,000.00 |
| Mar 31, 2022 | 134,000.00 |
| Mar 31, 2022 | 134,000.00 |